Sign Up Today and Learn More About Massive Bio Stock
Invest in or calculate the value of your shares in Massive Bio or other pre-IPO companies through EquityZen's platform.

Massive Bio Stock (MASB)
Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.
About Massive Bio Stock
Founded
2015
Headquarters
New York, NY, US
Industries
Software, Artificial Intelligence, Data and Analytics
Massive Bio Press Mentions
Stay in the know about the latest news on Massive Bio
Massive Bio Receives CNIL Certification for GDPR Compliance
einpresswire • Apr 14, 2025
Massive Bio Receives CNIL Certification for GDPR Compliance
businesswire • Apr 14, 2025
Flatiron Health, Massive Bio partner to improve clinical trial access
mobihealthnews • Apr 09, 2025
Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025
businesswire • Jan 15, 2025
Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at JPM 2025
morningstar • Jan 15, 2025
Massive Bio Management
Leadership team at Massive Bio
CEO & Co-Founder
Selin Kurnaz
Co-Founder & Chief Medical Officer
Arturo Loaiza-Bonilla

Join now and verify your accreditation status to gain access to:
- Massive Bio Current Valuation
- Massive Bio Stock Price
- Massive Bio Management
- Available deals in Massive Bio and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Massive Bio Cap Table and Funding History by Share Class and Liquidity Preferences
- Massive Bio Revenue and Financials
- Massive Bio Highlights
- Massive Bio Business Model
- Massive Bio Risk Factors
- Massive Bio Research Report from SACRA Research
Trading Massive Bio Stock
How to invest in Massive Bio stock?
Accredited investors can buy pre-IPO stock in companies like Massive Bio through EquityZen funds. These investments are made available by existing Massive Bio shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Massive Bio stock?
Shareholders can sell their Massive Bio stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."